Parecer de pré-exame
#6.23
04/18/2023
RPI 2728
Application data
Number
112020023012Type
Filing
Publication
PCT
US2019033260 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 04/18/2023. We update with every new RPI gazette, published weekly.
Applicants
EAGLE PHARMACEUTICALS, INC.
US
Inventors
C. W. (pessoa física)
US
J. C. (pessoa física)
US
IPC Classification
Priority claims
US
62/674,394 · 05/21/2018
Abstract
A divulgação refere-se a formulações líquidas de dantroleno, ou de um sal farmaceuticamente aceitável do mesmo, e a métodos de seu uso no tratamento de doença.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
04/18/2023
RPI 2728
#15.35
12/14/2021
RPI 2658
#1.3
02/02/2021
RPI 2613
#1.1
11/24/2020
RPI 2603
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.